Gene-based vaccine approaches
03 February 2021
•
OA12
•
15:00
>
16:00
•
Gene-based vaccine approaches
•
Live channel 1
15:00
•
OA12.01
•
Fine-tuning of <i>in vitro</i> transcribed mRNA for optimising a vaccine platform against HIV-1
See abstract
15:08
•
OA12.02
•
Comparison of co-immunization of DNA and protein in the same anatomical sites and in contralateral sites to identify mechanisms of protective immune response
See abstract
15:16
•
OA12.03
•
Tetravalent immunogen assembled from conserved regions of HIV-1 and delivered as mRNA demonstrates potent preclinical T cell immunogenicity and breadth
See abstract
15:24
•
OA12.04LB
•
A VSV-based HIV-1 vaccine provides protection in macaques against low dose cross-clade SHIVenv_SF162_P3 challenge
See abstract
15:32
•
OA12.05
•
Improved in vitro expression and in vivo immunogenicity of a candidate MVA-vectored HIV-1 vaccine compared to SAAVI MVA-C
See abstract
15:40
•
OA12.06
•
Live Q&A
See abstract
|